A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant

Falloon Judith; Ji Fei; Curtis Craig; Bart Stephan; Sheldon Eric; Krieger Diane; Dubovsky Filip; Lambert Stacie; Takas Therese; Villafana Tonya; Esser Mark T.

首页> 外文期刊>Vaccine >A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant

【24h】

A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant

机译：呼吸道合胞病毒F蛋白疫苗在有或没有Toll样受体4激动剂和稳定乳剂佐剂的情况下在人类中进行的1a期随机研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Respiratory syncytial virus (RSV) causes significant illness in older adults resulting in substantial health and economic impact. A successful vaccine would reduce morbidity in this growing segment of the population.

机译：背景：呼吸道合胞病毒（RSV）在老年人中引起重大疾病，对健康和经济产生重大影响。成功的疫苗将减少人口的这个不断增长的部分的发病率。

著录项

来源
《Vaccine》 |2016年第25期|共8页
作者
Falloon Judith; Ji Fei; Curtis Craig; Bart Stephan; Sheldon Eric; Krieger Diane; Dubovsky Filip; Lambert Stacie; Takas Therese; Villafana Tonya; Esser Mark T.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Respiratory syncytial virus; Vaccine; Adult; Adjuvant; Cell-mediated immunity;

机译：呼吸道合胞病毒;疫苗;成人;佐剂;细胞介导的免疫;

相似文献

外文文献
专利

1. A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant [J] . Falloon Judith, Ji Fei, Curtis Craig, Vaccine . 2016,第25期

机译：呼吸道合胞病毒F蛋白疫苗在有或没有Toll样受体4激动剂和稳定乳剂佐剂的情况下在人类中进行的1a期随机研究
2. A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant [J] . Langley Joanne M., Aggarwal Naresh, Toma Azhar, The Journal of Infectious Diseases . 2017,第1期

机译：随机，受控，观测的观察者致盲的阶段1研究呼吸道合胞病毒疫苗的安全性和免疫原性，或没有明矾佐剂
3. Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study [J] . Vaccine . 2019,第20期

机译：健康成人呼吸道合胞病毒融合糖蛋白F亚单蛋白的安全性和免疫原性：1期，随机，观察者盲，控制，剂量升级研究的结果
4. PPARgamma- and Toll-Like Receptor-2 Agonists Might Have Therapeutical Value in Respiratory Syncytial Virus (RSV)-Induced Airway Diseases PPARgamma Agonists May Act in a PPARgamma-Independent Manner [C] . R. Arnold, W. Konig Collegium Internationale Allergologicum . 2007

机译：pParγ-和Toll样受体-2激动剂可能对呼吸道合胞病毒（RSV）的治疗值（RSV）诱导的气道疾病Pparγ激动剂可以以ppargamma独立的方式行事
5. The functional study of nonstructural proteins of human respiratory syncytial virus (RSV). [D] . Ling, Zhenhua. 2009

机译：人呼吸道合胞病毒（RSV）非结构蛋白的功能研究。
6. A Randomized Controlled Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant [O] . Joanne M. Langley, Naresh Aggarwal, Azhar Toma, -1

机译：有或没有明矾佐剂的呼吸道合胞病毒疫苗的安全性和免疫原性的随机对照观察者盲目的1期研究
7. A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant [O] . Falloon Judith, Ji Fei, Curtis Craig, 2016

机译：呼吸道合胞病毒F蛋白疫苗在有或没有Toll样受体4激动剂和稳定乳剂佐剂的情况下在人类中的1a期随机研究
8. Laboratory and Antigenic Studies of Respiratory Syncytial Virus;Evaluation of Respiratory Syncytial, Meningococcal,and Pneumococcal Polysaccharide Vaccines. [R] . forsyth,ben r. phillips,charles a. 1971

机译：呼吸道合胞病毒的实验室和抗原研究;呼吸道合胞体，脑膜炎球菌和肺炎球菌多糖疫苗的评估。

A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant

摘要

著录项

相似文献

相关主题

期刊订阅